Fabric’s AI platform will help identify and prioritize new genome variants associated with neuroimmune axis disorders and accelerate clinical diagnostics for these conditions.
Priced at $1,000 per sample, the new test promises to be competitive with other offerings in the market
while offering better cost transparency.
Hofher, Former Chief Scientific Officer of GeneDx, is the latest addition to Fabric Genomics’ expanding leadership team
A new study in Nature Communications describes and examines the performance of Rady Children’s Institute for Genomic Medicine’s Genome-to-Treatment (GTRx™), a clinical decision support tool on which Fabric is a research collaborator.
Fabric’s PHEVOR WGS algorithm used in recent University of Utah School of Medicine study featured in npj Genomic Medicine: “A dominant negative ADIPOQ mutation in a diabetic family with renal disease, hypoadiponectinemia, and hyperceramidemia”
BeginNGS™ to accelerate newborn screening by rapid whole genome sequencing to help diagnose and treat genetic diseases with available therapies, Fabric honored to have been a collaborator
Fabric Genomics will provide the AI-based platform used to support the interpretation of clinical whole genomes and custom assays.
Element Biosciences and Fabric Genomics to explore commercialization of end-to-end clinical application solutions based on Element’s AVITI system and the Fabric Enterprise clinical interpretation platform.
GenomeWeb looks at two recent studies that lend support to Fabric Genomics’ artificial intelligence-based algorithm in helping to diagnose genetic diseases, providing further validation of the end-to-end software tool intended to help labs launch genomic testing programs.
New England Journal of Medicine publication showcases technology-driven variant detection platforms in accurately identifying causative genetic mutations
